Perinatal brain injury and regulation of transcription

Ying Chao Chang, Chao-Ching Huang

Research output: Contribution to journalReview article

47 Citations (Scopus)

Abstract

Purpose of review: Perinatal hypoxic-ischemic brain injury is a major cause of mortality and morbidity in infants. The understanding of transcription factor activation leading to prosurvival gene expression is important as it pertains to the development of new therapy. Here, we highlight the regulation of transcription factors that potentially could promote neuro-survival in the immature brain. Recent findings: cAMP response element binding protein (CREB), nuclear factor-κB (NF-κB) and hypoxia-induciblefactor 1 (HIF-1) are developmentally regulated in the neural system, and are necessary for the induction of preconditioning against hypoxic-ischemia. CREB and NF-κB are also involved in the regulation of synaptic plasticity, and learning and memory. CREB phosphorylation is sufficient and necessary for survival in adult and immature neurons, and NF-κB activation in neurons could promote survival, whereas activation in glial cells enhances neuronal death. Although HIF-1 is necessary for hypoxic preconditioning, paradoxically, in the absence of preconditioning, this factor promotes ischemia-induced neuronal death. Erythropoietin, one of the HIF-1 targeted genes, is potently neuroprotective and may be beneficial in treating newborns with hypoxic-ischemic brain damage. Summary: Drugs that activate the specific signaling leading to the transcriptional activation of prosurvival genes may provide therapy for the treatment of perinatal hypoxic-ischemic brain injury. Investigation of the transcriptional mechanisms of neuro-survival is likely to reveal other novel transcription factors whose activation by small molecules or drugs will complement current medication in activating the salutary gene program.

Original languageEnglish
Pages (from-to)141-147
Number of pages7
JournalCurrent Opinion in Neurology
Volume19
Issue number2
DOIs
Publication statusPublished - 2006 Apr 1

Fingerprint

Cyclic AMP Response Element-Binding Protein
Brain Injuries
Transcription Factors
Transcriptional Activation
Ischemia
Genes
Neurons
Brain Hypoxia
Neuronal Plasticity
Erythropoietin
Neuroglia
Pharmaceutical Preparations
Therapeutics
Phosphorylation
Learning
Newborn Infant
Morbidity
Gene Expression
Mortality
Brain

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

@article{13d9185cd4a24d638cb42be75e8f8c78,
title = "Perinatal brain injury and regulation of transcription",
abstract = "Purpose of review: Perinatal hypoxic-ischemic brain injury is a major cause of mortality and morbidity in infants. The understanding of transcription factor activation leading to prosurvival gene expression is important as it pertains to the development of new therapy. Here, we highlight the regulation of transcription factors that potentially could promote neuro-survival in the immature brain. Recent findings: cAMP response element binding protein (CREB), nuclear factor-κB (NF-κB) and hypoxia-induciblefactor 1 (HIF-1) are developmentally regulated in the neural system, and are necessary for the induction of preconditioning against hypoxic-ischemia. CREB and NF-κB are also involved in the regulation of synaptic plasticity, and learning and memory. CREB phosphorylation is sufficient and necessary for survival in adult and immature neurons, and NF-κB activation in neurons could promote survival, whereas activation in glial cells enhances neuronal death. Although HIF-1 is necessary for hypoxic preconditioning, paradoxically, in the absence of preconditioning, this factor promotes ischemia-induced neuronal death. Erythropoietin, one of the HIF-1 targeted genes, is potently neuroprotective and may be beneficial in treating newborns with hypoxic-ischemic brain damage. Summary: Drugs that activate the specific signaling leading to the transcriptional activation of prosurvival genes may provide therapy for the treatment of perinatal hypoxic-ischemic brain injury. Investigation of the transcriptional mechanisms of neuro-survival is likely to reveal other novel transcription factors whose activation by small molecules or drugs will complement current medication in activating the salutary gene program.",
author = "Chang, {Ying Chao} and Chao-Ching Huang",
year = "2006",
month = "4",
day = "1",
doi = "10.1097/01.wco.0000218229.73678.a8",
language = "English",
volume = "19",
pages = "141--147",
journal = "Current Opinion in Neurology",
issn = "1350-7540",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Perinatal brain injury and regulation of transcription. / Chang, Ying Chao; Huang, Chao-Ching.

In: Current Opinion in Neurology, Vol. 19, No. 2, 01.04.2006, p. 141-147.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Perinatal brain injury and regulation of transcription

AU - Chang, Ying Chao

AU - Huang, Chao-Ching

PY - 2006/4/1

Y1 - 2006/4/1

N2 - Purpose of review: Perinatal hypoxic-ischemic brain injury is a major cause of mortality and morbidity in infants. The understanding of transcription factor activation leading to prosurvival gene expression is important as it pertains to the development of new therapy. Here, we highlight the regulation of transcription factors that potentially could promote neuro-survival in the immature brain. Recent findings: cAMP response element binding protein (CREB), nuclear factor-κB (NF-κB) and hypoxia-induciblefactor 1 (HIF-1) are developmentally regulated in the neural system, and are necessary for the induction of preconditioning against hypoxic-ischemia. CREB and NF-κB are also involved in the regulation of synaptic plasticity, and learning and memory. CREB phosphorylation is sufficient and necessary for survival in adult and immature neurons, and NF-κB activation in neurons could promote survival, whereas activation in glial cells enhances neuronal death. Although HIF-1 is necessary for hypoxic preconditioning, paradoxically, in the absence of preconditioning, this factor promotes ischemia-induced neuronal death. Erythropoietin, one of the HIF-1 targeted genes, is potently neuroprotective and may be beneficial in treating newborns with hypoxic-ischemic brain damage. Summary: Drugs that activate the specific signaling leading to the transcriptional activation of prosurvival genes may provide therapy for the treatment of perinatal hypoxic-ischemic brain injury. Investigation of the transcriptional mechanisms of neuro-survival is likely to reveal other novel transcription factors whose activation by small molecules or drugs will complement current medication in activating the salutary gene program.

AB - Purpose of review: Perinatal hypoxic-ischemic brain injury is a major cause of mortality and morbidity in infants. The understanding of transcription factor activation leading to prosurvival gene expression is important as it pertains to the development of new therapy. Here, we highlight the regulation of transcription factors that potentially could promote neuro-survival in the immature brain. Recent findings: cAMP response element binding protein (CREB), nuclear factor-κB (NF-κB) and hypoxia-induciblefactor 1 (HIF-1) are developmentally regulated in the neural system, and are necessary for the induction of preconditioning against hypoxic-ischemia. CREB and NF-κB are also involved in the regulation of synaptic plasticity, and learning and memory. CREB phosphorylation is sufficient and necessary for survival in adult and immature neurons, and NF-κB activation in neurons could promote survival, whereas activation in glial cells enhances neuronal death. Although HIF-1 is necessary for hypoxic preconditioning, paradoxically, in the absence of preconditioning, this factor promotes ischemia-induced neuronal death. Erythropoietin, one of the HIF-1 targeted genes, is potently neuroprotective and may be beneficial in treating newborns with hypoxic-ischemic brain damage. Summary: Drugs that activate the specific signaling leading to the transcriptional activation of prosurvival genes may provide therapy for the treatment of perinatal hypoxic-ischemic brain injury. Investigation of the transcriptional mechanisms of neuro-survival is likely to reveal other novel transcription factors whose activation by small molecules or drugs will complement current medication in activating the salutary gene program.

UR - http://www.scopus.com/inward/record.url?scp=33645070308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645070308&partnerID=8YFLogxK

U2 - 10.1097/01.wco.0000218229.73678.a8

DO - 10.1097/01.wco.0000218229.73678.a8

M3 - Review article

C2 - 16538087

AN - SCOPUS:33645070308

VL - 19

SP - 141

EP - 147

JO - Current Opinion in Neurology

JF - Current Opinion in Neurology

SN - 1350-7540

IS - 2

ER -